Biogen announces job cuts, turns focus to Alzheimer's drug launch
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Biogen (BIIB) tops earnings expectations, reveals workforce reduction
July 25, 2023 9:22 AM EDTBiogen (NASDAQ: BIIB) shares are trading higher premarket after topping second-quarter earnings and revenue expectations. The company also revealed it will cut jobs in order to save costs.
BIIB reported Q2 EPS of $4.02, $0.24 better than the analyst estimate of $3.78, while revenue for the quarter came... More
